COVID-19, PREGNANT AND FEATURES OF THE STATE OF HYPERCOAGULABILITY
Keywords:
COVID-19, pregnancy, SARS-CoV-2Abstract
COVID-19 is a global health emergency that can cause serious health problems during pregnancy. The aim of the study was: to assess the state of the hemostasis system in pregnant women with COVID-19. The research materials selected 49 pregnant women hospitalized in medical institutions of the Samarkand region due to COVID-19. In the results of the study, we mainly paid attention to the general condition of women depending on the trimester of pregnancy, the reasons for hospitalization, comorbid conditions, changes in general tests, coagulogram, in the blood coagulation system, as well as the outcomes of pregnancy and childbirth. Conclusion. As the burden and magnitude of COVID-19 continues to grow globally, there is still much to be learned about the impact of COVID-19 on pregnancy and perinatal and neonatal outcomes
References
Ahmed S, Zimba O, Gasparyan AY. Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad. Clin Rheumatol. 2020; 39: 2529–43.
Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, et al. Global COVID-19 Thrombosis Collaborative Group. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost. 2020; 120 (7): 1004–24.
Buonsenso D, Raffaelli F, Tamburrini E, Biasucci DG, Salvi S, Smargiassi A, et al. Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women.
Ultrasound Obstet Gynecol. 2020; 56: 106–9.Liu X, Zhang R, He G. Hematological findings in coronavirusdisease 2019: indications of progression of disease. Ann Hematol.2020;99:1421–8.
Fei Y, Tang N, Liu H, Cao W. Coagulation dysfunction: a hallmarkin COVID-19. Arch Pathol Lab Med. 2020; 144: 1223–9.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.